Persistent Atrial Fibrillation: The Role of Left Atrial Posterior Wall Isolation and Ablation Strategies
- PMID: 34300301
- PMCID: PMC8304563
- DOI: 10.3390/jcm10143129
Persistent Atrial Fibrillation: The Role of Left Atrial Posterior Wall Isolation and Ablation Strategies
Abstract
Atrial fibrillation (AF) is a global disease with rapidly rising incidence and prevalence. It is associated with a higher risk of stroke, dementia, cognitive decline, sudden and cardiovascular death, heart failure and impairment in quality of life. The disease is a major burden on the healthcare system. Paroxysmal AF is typically managed with medications or endocardial catheter ablation to good effect. However, a large proportion of patients with AF have persistent or long-standing persistent AF, which are more complex forms of the condition and thus more difficult to treat. This is in part due to the progressive electro-anatomical changes that occur with AF persistence and the spread of arrhythmogenic triggers and substrates outside of the pulmonary veins. The posterior wall of the left atrium is a common site for these changes and has become a target of ablation strategies to treat these more resistant forms of AF. In this review, we discuss the role of the posterior left atrial wall in persistent and long-standing persistent AF, the limitations of current endocardial-focused treatment strategies, and future perspectives on hybrid epicardial-endocardial approaches to posterior wall isolation or ablation.
Keywords: convergent ablation; hybrid ablation; persistent atrial fibrillation; posterior wall.
Conflict of interest statement
R. A. Kaba is a consultant for Daiichi Sankyo, Bayer, Atricure and Biotronik. A. Momin is a consultant for Atricure. A. J. Camm has received personal fees from Abbott, Boston Scientific, Medtronic and Atricure.
Figures
References
-
- Calkins H., Hindricks G., Cappato R., Kim Y.H., Saad E.B., Aguinaga L., Akar J.G., Badhwar V., Brugada J., Camm J., et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14:e275–e444. doi: 10.1016/j.hrthm.2017.05.012. - DOI - PMC - PubMed
-
- Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomstrom-Lundqvist C., Boriani G., Castella M., Dan G.A., Dilaveris P.E., et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) Eur. Heart J. 2020 doi: 10.1093/eurheartj/ehaa612. - DOI - PubMed
-
- Kaba R., Ahmed O., Momin A. Electrical isolation of the left atrial appendage—A new frontier in the treatment for atrial fibrillation. J. Cardiovasc. Dis. Diagn. 2020;8:1–6. doi: 10.37421/jcdd.2020.8.411. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
